{"id":22141,"date":"2024-01-24T07:00:00","date_gmt":"2024-01-24T06:00:00","guid":{"rendered":"https:\/\/ggba.swiss\/?p=22141"},"modified":"2024-01-23T10:10:52","modified_gmt":"2024-01-23T09:10:52","slug":"timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/","title":{"rendered":"Timeline secures CHF 56 million to propel its pioneering role in longevity and healthy aging"},"content":{"rendered":"\n

Founded in 2007 by Chris Rinsch and Patrick Aebischer as a spin-off from the EPFL, Timeline<\/a> (formerly Amazentis) has been on the cutting edge of developing innovative solutions for healthy aging. The company’s core technology, Mitopure, has been the cornerstone of this progress.<\/p>\n\n\n\n

With over 15 years of research backing, Mitopure is clinically proven to target a key cellular longevity pathway, focusing on recycling and renewing mitochondria, the cell’s powerhouse. This technology is central to supporting muscle strength, cognition, immune resilience, and skin vitality, among other aging aspects. The CHF 56 million investment reflects the robust confidence of investors in Timeline’s proprietary technology and its potential to revolutionize the longevity and health span sector.<\/p>\n\n\n\n

L\u2019Or\u00e9al, through its Deputy CEO Barbara Lavernos, highlighted the intersection of longevity with beauty, stating: “Longevity is a new definition of beauty… Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.”<\/p>\n\n\n\n

Expanding into a leading consumer health brand in the longevity sector<\/h4>\n\n\n\n

Nestl\u00e9, a long-standing investor since 2019, remains impressed with Timeline’s potential. Anna Mohl, CEO of Nestl\u00e9 Health Science, noted the exponential potential of Mitopure technology in nutrition and aging. The joining of L\u2019Or\u00e9al as an investor and strategic partner is expected to propel Mitopure technology to new heights and broaden its applications. The funds from this investment will be channeled towards expanding Timeline into a leading consumer health brand in the longevity sector, focusing on science, product categories, and markets across food, beauty, and health sectors.<\/p>\n","protected":false},"excerpt":{"rendered":"

Timeline, a Vaud-based biotech leader in healthy aging and longevity, has announced a pivotal CHF 56 million investment in its Series D financing round.<\/p>\n","protected":false},"author":6,"featured_media":22142,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[957,894,928,958,902],"class_list":["post-22141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-cosmetics","tag-financing","tag-food-beverages","tag-foodtech","tag-personalized-medicine"],"acf":[],"yoast_head":"\nTimeline secures CHF 56M to propel its healthy aging solutions<\/title>\n<meta name=\"description\" content=\"Timeline, a Vaud-based biotech leader in healthy aging and longevity, has raised CHF 56 million investment in its Series D financing round.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Timeline secures CHF 56M to propel its healthy aging solutions\" \/>\n<meta property=\"og:description\" content=\"Timeline, a Vaud-based biotech leader in healthy aging and longevity, has raised CHF 56 million investment in its Series D financing round.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-24T06:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2360\" \/>\n\t<meta property=\"og:image:height\" content=\"1622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Timeline secures CHF 56 million to propel its pioneering role in longevity and healthy aging\",\"datePublished\":\"2024-01-24T06:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/\"},\"wordCount\":271,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg\",\"keywords\":[\"Cosmetics\",\"Financing\",\"Food & Beverages\",\"FoodTech\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/\",\"url\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/\",\"name\":\"Timeline secures CHF 56M to propel its healthy aging solutions\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg\",\"datePublished\":\"2024-01-24T06:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Timeline, a Vaud-based biotech leader in healthy aging and longevity, has raised CHF 56 million investment in its Series D financing round.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg\",\"width\":2360,\"height\":1622,\"caption\":\"Timeline\u2019s new funding round, led by BOLD (Business Opportunities for L\u2019Or\u00e9al Development), includes strategic investments from industry giants L\u2019Or\u00e9al and Nestl\u00e9. | \u00a9 Timeline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Timeline secures CHF 56 million to propel its pioneering role in longevity and healthy aging\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Timeline secures CHF 56M to propel its healthy aging solutions","description":"Timeline, a Vaud-based biotech leader in healthy aging and longevity, has raised CHF 56 million investment in its Series D financing round.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/","og_locale":"en_US","og_type":"article","og_title":"Timeline secures CHF 56M to propel its healthy aging solutions","og_description":"Timeline, a Vaud-based biotech leader in healthy aging and longevity, has raised CHF 56 million investment in its Series D financing round.","og_url":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-01-24T06:00:00+00:00","og_image":[{"width":2360,"height":1622,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Timeline secures CHF 56 million to propel its pioneering role in longevity and healthy aging","datePublished":"2024-01-24T06:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/"},"wordCount":271,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg","keywords":["Cosmetics","Financing","Food & Beverages","FoodTech","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/","url":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/","name":"Timeline secures CHF 56M to propel its healthy aging solutions","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg","datePublished":"2024-01-24T06:00:00+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Timeline, a Vaud-based biotech leader in healthy aging and longevity, has raised CHF 56 million investment in its Series D financing round.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/01\/Timeline-Oreal-2360x1622-1.jpg","width":2360,"height":1622,"caption":"Timeline\u2019s new funding round, led by BOLD (Business Opportunities for L\u2019Or\u00e9al Development), includes strategic investments from industry giants L\u2019Or\u00e9al and Nestl\u00e9. | \u00a9 Timeline"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/timeline-secures-chf-56-million-to-propel-its-pioneering-role-in-longevity-and-healthy-aging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Timeline secures CHF 56 million to propel its pioneering role in longevity and healthy aging"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/22141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=22141"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/22141\/revisions"}],"predecessor-version":[{"id":22145,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/22141\/revisions\/22145"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/22142"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=22141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=22141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=22141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}